PF-06667272

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-06667272, covering 2017-10-19 to 2017-10-19. Get the full timeline:

Most recent: Clinical Trial Update: First in Human Study for PF-06667272 [Phase 1]